Central blood pressure as an index of antihypertensive control: Determinants and potential value

Canadian Journal of Cardiology

Volumn 30, Issue 5 S, 2014, Pages

  Trudeau, Luc ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ANTIHYPERTENSIVE THERAPY; AORTA PRESSURE; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; AUGMENTATION INDEX; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAROTID ARTERY; CENTRAL AORTIC PRESSURE; CENTRAL BLOOD PRESSURE; CENTRAL PULSE WAVE; DIASTOLIC BLOOD PRESSURE; DRUG RESPONSE; FEMORAL ARTERY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE CONTRACTION; HUMAN; PREDICTIVE VALUE; PROGNOSIS; PULSE WAVE; RADIAL PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE VALUE; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW (TOPIC); SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CANADA; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION; MALE; PULSATILE FLOW; PULSE; RADIAL ARTERY; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TREATMENT OUTCOME; VASCULAR RESISTANCE; VASCULAR STIFFNESS;

EID: 84898857590     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.03.010     Document Type: Review

References (46)

1. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data from one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
2. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009, 338:b1665.
3. Safar M.E., Levy B.I., Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003, 107:2864-2869.
4. O'Rourke M.F. Pulsatile arterial hemodynamics in hypertension. Aus N Z Med 1976, 6(suppl 2):40-48.
5. McEniery C.M., Yasmin, McDonnell B., et al. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension 2008, 51:1476-1482.
6. Siebenhofer A., Kemp C.R., Sutton A.J., Williams B. The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography. JHum Hypertens 1999, 13:625-629.
7. Kelly R., Hayward C., Avolio A., O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation 1989, 80:1652-1659.
8. Mancia G., De Backer G., Dominniczak A. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). JHypertens 2007, 25:1105-1187.
9. O'Brien E., Waeber B., Parati G., Staessen J., Myers M.G. Blood pressure measuring devices: recommendations of the European Society of the European Society of Hypertension. BMJ 2001, 322:531-536.
10. ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology. JHypertens 2013, 31:1925-1938.
11. Mitchell G.F., Hwang S.J., Vasan R.S., et al. Arterial stiffness and cardiovascular events; the Framingham Heart Study. Circulation 2010, 121:505-511.
12. Vlachopoulos C., Aznaouidis K., Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness. JAm Coll Cardiol 2010, 55:1318-1327.
13. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010, 31:2338-2350. The Reference Values for Arterial Stiffness' Collaboration.
14. Boutouyrie P., Bussy C., Lacolley P., et al. Association between local pulse pressure, mean blood pressure and large-artery remodelling. Circulation 1999, 100:1987-1993.
15. Saba P.S., Roman M.J., Pini R., et al. Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects. JAm Coll Cardiol 1993, 22:1873-1880.
16. Roman M.J., Ganan A., Saba P.S., et al. Impact of arterial stiffening on left ventricular structure. Hypertension 2000, 36:489-494.
17. Sato E., Feke G.T., Appelbaum E.Y., et al. Association between systemic arterial stiffness and age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2006, 244:963-971.
18. Cohen D.L., Townsend R.R. Central blood pressure and chronic kidney disease progression. Int J Nephrol 2011, 2011:407801.
19. Roman M.J., Devereux R.B., Kizer J.R., et al. Central blood pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007, 50:197-203.
20. Safar M.E., Blacher J., Pannier B., et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002, 39:735-738.
21. Pini R., Cavallini M.C., Palmieri V., et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population. JAm Coll Cardiol 2008, 51:2432-2439.
22. Kaess B.M., Rong J., Larson M.G. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 2012, 308:875-881.
23. Cheng H.M., Chuang S.Y., Sung S.H., Chen C.H. Derivation and validation of diagnostic thresholds for central blood pressure measurements based on long-term cardiovascular risks. JAm Coll Cardiol 2013, 62:1780-1787.
24. Wing L.M., Reid C.M., Ryan P., West M.J. Acomparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. NEngl J Med 2003, 348:583-592.
25. Dahlöf B., Devereux R.B., Kjeldsen S.E., et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002, 359:995-1003.
26. Dahlof B., Sever P.S., Poulter N.R. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005, 366:895-906. for the ASCOT investigators.
27. Jamerson K., Weber M.A., Bakris G.L., et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. NEngl J Med 2008, 359:2417-2428.
28. Williams B., Lacy P.S., Thom S.M., et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes (the CAFE study). Circulation 2006, 113:1213-1225.
29. Sharman J.E., Marwick T.H., Gilroy D., et al. Randomized trial of guiding hypertension management using central aortic blood pressure compared with best-practice care - the BP GUIDE study. Hypertension 2013, 62:1138-1145.
30. Mahmud A., Feely J. Antihypertensive drugs and arterial stiffness. Expert Rev Cardiovasc Ther 2003, 1:65-78.
31. Winer N., Weber M.A., Sowers J.R. The effect of antihypertensive drugs on vascular compliance. Curr Hypertens Rep 2001, 3:297-304.
32. Benetos A., Lafleche A., Asmar R., et al. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension. JHum Hypertens 1996, 10:77-82.
33. DeCesaris R., Ranieri G., Filitti V., Andriani A. Large artery compliance in essential hypertension. Effects of calcium antagonism and β-blocking. Am J Hypertens 1992, 5:624-628.
34. Chen C.H., Ting C.T., Lin S.J., Hsu T.L., Siu C.O. Different effects of fosinopril and atenolol on wave reflection in hypertension patients. Hypertension 1995, 25:1034-1041.
35. DeCesaris R., Ranieri G., Filetti V., Andriani A., Bonfantivo M.V. Forearm arterial distensibility in patients with hypertension: comparative effects of long-term ACE inhibition and β-blocking. Clin Pharmocol 1993, 53:360-367.
36. Heffernan K.S., Suryadevara R., Patvardhan E.A., et al. Effect of atenolol vs metoprolol succinate on vascular function in patients with hypertension. Clin Cardiol 2011, 34:39-44.
37. Asmar R., Kerihuel J.C., Girerd X.J., Safar M.E. Effect of bisoprolol on blood pressure and arterial hemodynamics. Am J Cardiol 1991, 68:61-64.
38. Agabiti-Rosei E., Porteri E., Rizzoni D. Arterial stiffness, hypertension, and rational use of nebivolol. Vasc Health Risk Manag 2009, 5:353-360.
39. Kim E.J., Song W.H., Lee J.U., et al. Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: a prospective, randomized, open, blinded end point, multicenter study. Hypertens Res 2014, 37:50-56.
40. Hackam D.G., Quinn R.R., Ravani P., et al. Canadian Hypertension Education Program. The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiology 2013, 29:528-542.
41. Broeders M.A., Dorendans P.A., Bekkers B.C., et al. Nebivolol: a third-generation β-blocker that augments vascular nitric oxide release. Circulation 2000, 102:677-684.
42. Shah N.K., Smith S.M., Nichols W.W., et al. Carvedilol reduces aortic wave reflection and improves left ventricular/vascular coupling: a comparison with atenolol (CENTRAL Study). JClin Hypertens (Greenwich) 2001, 13:917-924.
43. Dhakam Z., McEniery C.M., Burton T., Brown M.J., Wilkinson B. Acomparison of atenolol and nebivolol in isolated systolic hypertension. JHypertens 2008, 26:351-356.
44. Redón J, Pascual-Izuel JM, Rodilla E, Calaforra O, Almirall J. Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study. Blood Press 2013. [Epub ahead of print].
45. Kampus P., Serg M., Kals J., Eha J. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness. Hypertension 2011, 57:1122-1128.
46. Vitale C., Marazzi G., Iellamo F., Spoletini I., Volterrani M. Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: the NINFE study. Int J Cardiol 2011, 155:279-284.